Tesofensine is an investigational compound initially developed for Alzheimer's disease, but later explored for its potential in weight management. It acts as a triple monoamine reuptake inhibitor, affecting serotonin, norepinephrine, and dopamine. Research has primarily focused on its impact on appetite and satiety, with clinical trials examining its efficacy and safety profile. While not currently approved for medical use in most regions, studies have investigated its potential as an anti-obesity agent, particularly in individuals with a high body mass index (BMI). (Sources: PubChem, DrugBank)
Deep dive
Tap a section to expand.
Known interactions
Category rule: supplement × medication
Note
Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).
Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist.
Category rule: vitamin × medication
Note
Certain vitamins interact with specific medications (e.g., vitamin K with blood thinners).
Specific pairs are checked against a licensed source; confirm with your provider.
Frequently asked
Sources referenced
* DrugBank
* PubChem
* Examine.com
* National Institutes of Health (NIH) Clinical Trials Database
* Cochrane Library
Stackwise compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician.
Related compounds
Others in the medication category or studied for the same goals.
